骨髓增殖性瘤:年轻患者,当前数据和未来考虑
Marta Sobas1, Jean-Christophe Ianotto2, Jean-Jacques Kiladjian3
1Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland. marta.sobas@gmail.com.
Annals of hematology
|August 7, 2024
概括
费城阴性慢性骨髓扩散性瘤 (MPNs) 在年轻患者中很少见,存在独特的诊断和管理挑战. 最佳治疗需要国际合作,以改善儿童MPN病例的结果和修改疾病进展.
科学领域:
- 血液学 血液学 血液学
- 儿科瘤学 儿科瘤学
- 遗传学 是一个遗传学.
背景情况:
- 费城阴性慢性骨髓扩散性瘤 (MPNs) 在儿童和年轻人中不常见.
- 关于MPN在年轻人群中的临床表现,遗传学,预后和管理的数据有限.
- 在这个年龄组中诊断的增加需要量身定制的方法.
研究的目的:
- 突出儿童和年轻成人患者中MPN的诊断和治疗挑战.
- 强调需要具体的管理策略,考虑到更长的预期寿命和独特的患者需求.
- 倡导国际合作在儿科MPN研究和治疗方案开发.
主要方法:
- 关于儿科和年轻成人MPN的当前文献的综述.
- 诊断困难的分析,包括较低的突变频率 (JAK2V617F,CALR) 和不同的血液细胞计数.
- 讨论长期挑战:心理社会需求,生育能力,怀孕和治疗副作用.
主要成果:
- 与成年人相比,儿童的诊断可能会因非典型的遗传特征和血液学发现而复杂化.
- 年轻的患者面临着独特的长期问题,包括心理社会支持,生育能力的维护和二次恶性瘤的风险.
- 成年MPN的确定的风险分层分数对于年轻人来说往往是不够的.
结论:
- 年轻患者中MPN的管理需要专门的策略,超出成人协议.
- 治疗的首要目标应该集中在改变疾病结果和改善长期生活质量上.
- 国际合作努力对于开发基于证据的管理协议和改善儿科MPN患者的护理至关重要.
相关概念视频
01:22Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:21Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K